ABVX Abivax S.A.
Healthcare$126.41+3.62%ClosedMarket Cap: $8.29B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
17.58
P/S
0.00
EV/EBITDA
-34.82
DCF Value
$8.25
FCF Yield
-1.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-165.2%
ROA
-57.5%
ROIC
-48.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | NaN% | $-199.6M | $-287.7M | $— | — |
| FY null | $0.00 | NaN% | $-246.1M | $-336.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-46.5M | $-48.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-47.2M | $-52.4M | $— | — |
| FY null | $0.00 | NaN% | $-173.0M | $-176.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-35.3M | $-38.8M | $— | — |
| Q4 null | $2.3M | 100.0% | $-92.5M | $-95.8M | $— | — |
| FY null | $0.00 | NaN% | $-127.4M | $-147.7M | $— | — |
| Q2 null | $2.2M | 100.0% | $-39.5M | $-52.0M | $— | — |
| Q4 null | $2.2M | 100.0% | $-38.8M | $-40.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-64.8M | $-60.7M | $— | — |
| Q2 null | $2.2M | 100.0% | $-18.6M | $-29.6M | $— | — |